CASELLI, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 3.936
NA - Nord America 2.452
EU - Europa 1.103
SA - Sud America 746
AF - Africa 81
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.328
Nazione #
US - Stati Uniti d'America 2.342
SG - Singapore 1.764
CN - Cina 737
BR - Brasile 592
VN - Vietnam 454
HK - Hong Kong 431
IT - Italia 274
FR - Francia 221
NL - Olanda 165
JP - Giappone 122
KR - Corea 95
FI - Finlandia 90
DE - Germania 83
GB - Regno Unito 79
IN - India 75
BD - Bangladesh 60
CA - Canada 51
AR - Argentina 49
MX - Messico 34
ZA - Sudafrica 29
ES - Italia 28
ID - Indonesia 28
EC - Ecuador 27
IQ - Iraq 26
AT - Austria 22
CO - Colombia 22
PL - Polonia 19
SE - Svezia 19
UZ - Uzbekistan 16
MA - Marocco 15
SA - Arabia Saudita 15
VE - Venezuela 15
TR - Turchia 14
UA - Ucraina 14
PK - Pakistan 13
IL - Israele 12
LT - Lituania 12
CL - Cile 10
PE - Perù 10
PH - Filippine 10
GR - Grecia 9
IE - Irlanda 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
RU - Federazione Russa 8
TN - Tunisia 8
AU - Australia 7
LV - Lettonia 7
HR - Croazia 6
KE - Kenya 6
UY - Uruguay 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
HU - Ungheria 5
KZ - Kazakistan 5
MY - Malesia 5
AL - Albania 4
AZ - Azerbaigian 4
JM - Giamaica 4
LB - Libano 4
LK - Sri Lanka 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AM - Armenia 3
BE - Belgio 3
CY - Cipro 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
NP - Nepal 3
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GE - Georgia 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CM - Camerun 1
CU - Cuba 1
CV - Capo Verde 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
IM - Isola di Man 1
Totale 8.313
Città #
Singapore 1.059
Santa Clara 583
Hong Kong 427
San Jose 330
Beijing 213
Ashburn 203
Hefei 200
Lauterbourg 179
Los Angeles 178
Ho Chi Minh City 158
Dallas 134
Hanoi 110
Tokyo 105
Seoul 93
New York 60
Buffalo 54
São Paulo 52
Helsinki 43
Pisa 41
Orem 39
Cascina 37
Frankfurt am Main 28
Lappeenranta 24
Montreal 23
Rio de Janeiro 22
Council Bluffs 21
Turku 21
Biên Hòa 19
Brooklyn 17
Haiphong 17
Phoenix 17
Stockholm 17
Warsaw 17
Johannesburg 16
London 16
Baghdad 15
Chennai 15
Naples 15
Nuremberg 15
Tashkent 15
Atlanta 14
Düsseldorf 14
Milan 14
Rome 14
Poplar 13
Florence 12
Guangzhou 12
Houston 12
Toronto 12
Belo Horizonte 11
Chicago 11
Da Nang 11
Hải Dương 11
Manchester 11
Mumbai 11
Munich 11
Quito 11
Bengaluru 10
Campinas 10
Denver 10
Brasília 9
Dhaka 9
Livorno 9
Minamishinagawa 9
Santo André 9
Elk Grove Village 8
Salvador 8
Vienna 8
Bologna 7
Curitiba 7
Dublin 7
Falkenstein 7
Kyiv 7
Lima 7
Manaus 7
Mexico City 7
Riga 7
Thái Bình 7
Ankara 6
Athens 6
Caracas 6
Charlotte 6
Fortaleza 6
Guarulhos 6
Guayaquil 6
Istanbul 6
Madrid 6
Montevideo 6
Ninh Bình 6
Piscataway 6
Porto Alegre 6
Riyadh 6
San Francisco 6
Sydney 6
Bogotá 5
Boston 5
Buenos Aires 5
Bắc Ninh 5
Can Tho 5
Detroit 5
Totale 5.148
Nome #
SMARTool: Interim Progress Report (M19-M30) 127
Health improvements by Understanding Residual Risk In CAd and NEw targets for prevention/treatment: Rationale and Research Protocol of the HURRICANE project 110
SMARTool - Periodic Technical Report - PART B (Period 2) 108
Plasma lipidomics and coronary plaque changes: a substudy of the SMARTool clinical trial 96
The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity? 90
Variations of circulating miRNA in paediatric patients with Heart Failure supported with Ventricular Assist Device: a pilot study 87
Effects of obesity on IL-33/ST2 system in heart, adipose tissue and liver: study in the experimental model of Zucker rats 85
Validated models for pre-test probability of stable coronary artery disease: a systematic review suggesting how to improve validation procedures 85
Association of circulating neutrophils with relative volume of lipid-rich necrotic core of coronary plaques in stable patients: a substudy of SMARTool european project 83
Impact of normalization strategy on cardiac expression of pro-inflammatory cytokines: Evaluation of reference genes in different human myocardial regions after Left Ventricular Assist Device support. 82
C-type natriuretic peptide transcriptomic profiling increases in human leukocytes of patients with chronic heart failure as a function of clinical severity 80
Discrimination capability of pretest probability of stable coronary artery disease: a systematic review and meta-analysis suggesting how to improve validation procedures 80
Long-term prognostic impact of fasting plasma glucose and myocardial flow reserve beyond other risk factors and heart disease phenotypes 78
Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure. 76
Effect of Neutrophil–Platelet Interactions on Cytokine-Modulated Expression of Neutrophil CD11b/CD18 (Mac-1) Integrin Complex and CCR5 Chemokine Receptor in Stable Coronary Artery Disease: A Sub-Study of SMARTool H2020 European Project 76
Blood M2-like Monocyte Polarization Is Associated with Calcific Plaque Phenotype in Stable Coronary Artery Disease: A Sub-Study of SMARTool Clinical Trial 76
Adrenomedullin and intermedin gene transcription is increased in leukocytes of patients with chronic heart failure at different stages of the disease (Peptides (2014) 55 (13-16)) 75
A possible role for ST2 as prognostic biomarker for COVID-19 74
A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome 74
Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial 72
Association of Circulating Heme Oxygenase-1, Lipid Profile and Coronary Disease Phenotype in Patients with Chronic Coronary Syndrome 71
Predictive added value of selected plasma lipids to a re-estimated minimal risk tool 68
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina 66
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS) 66
HDL Cholesterol, Leptin and Interleukin-6 Are Independent Predictors of Coronary Atherosclerotic Burden and Plaque Composition Assessed by Coronary Ct Angiography in Patient With Stable Angina. 64
Low HDL cholesterol and the eNOS Glu298Asp polymorphism are associated with inducible myocardial ischemia in patients with suspected stable coronary artery disease 64
Role of adiponectin system in insulin resistance 63
Changes in adiponectin system after ventricular assist device in pediatric heart failure 62
Epigenetic Regulation of Cardiac Troponin Genes in Pediatric Patients with Heart Failure Supported by Ventricular Assist Device 62
A different trend of heat shock proteins 90 mRNA and protein in hepatocellular carcinoma cell line-secreted extracellular vesicles. 59
Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population 58
Comparison of high-sensitive cardiac troponin T and I in patients with chronic coronary syndrome 57
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study 57
Novel predictive model of obstructive coronary artery disease combining clinical and biohumoral data 56
Expression profile of adrenomedullin and its specific receptors in liver tissues from patients with hepatocellular carcinoma and in tumorigenic cell line-secreted extracellular vesicles 56
ADIPONECTIN AND CARDIOVASCULAR RISK PREDICTION: STRATIFICATION OF CHEST PAIN PATIENTS BY A CLUSTER ANALYSIS 55
Focus on cardiac troponin complex: From gene expression to cardiomyopathy 55
EVINCI Study: Management, Integration and Communication of Clinical and Imaging Data 55
Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study 55
Myocardial interleukin-6 in the setting of left ventricular mechanical assistance: relation with outcome and C-reactive protein. 55
Regional cardiac expression of biomarker of biomarkers involved in apoptotic process in an experimental model of left ventricular pacing-induced heart failure 54
Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure 54
Innate Immunity and Coronary Atherosclerosis Progression: putative cellular and molecular marker. 53
SMARTool: Periodic Technical Report - Part B 53
Circulating high-sensitivity cardiac troponin T is a strong predictor of coronary atherosclerotic burden independently from the presence of inducible ischemia 52
Reference intervals for C-type natriuretic peptide plasma levels in healthy newborns and infants 52
CNP transcriptomic profiling in HF patients as a function of clinical severity 52
Increased plasma levels of osteopontin are associated with activation of the renin-aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy. 52
Circulating microRNA profiling in serum of pediatric patients with heart failure submitted to VAD implant 52
Integration of co-culture conditions and 3D gelatin methacryloyl hydrogels to improve human-induced pluripotent stem cells-derived cardiomyocytes maturation 52
Reference intervals for C-type natriuretic peptide plasma levels in healthy newborns and infants 51
A new integrated clinical-biohumoral model to predict functionally significant coronary artery disease in patients with chronic chest pain 51
PCSK9 and atherosclerosis: Looking beyond LDL regulation 50
C-TYPE NATRIURETIC PEPTIDE TRANSCRIPTOMIC PROFILING INCREASES IN LEUKOCYTES OF PATIENTS WITH CHRONIC HEART FAILURE AS A FUNCTION OF CLINICAL SEVERITY 50
Left Ventricular Assist Device Activates the Transcriptional Apoptotic Profile in Human Heart 49
Cardiac troponins: Mechanisms of release and role in healthy and diseased subjects 49
Apoptosis markers in the heart of minipigs with left ventricular pacing-induced heart failure 48
Rapid Plaque Progression Is Independently Associated With Hyperglycemia and Low HDL Cholesterol in Patients With Stable Coronary Artery Disease: A PARADIGM Study 48
Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device 48
Transcriptional Alterations of ET-1 Axis and DNA Damage in Lung Tissue of a Rat Obesity Model. 48
Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients with Stable Angina 48
Pathophysiology and molecular signalling in pediatric heart failure and VAD therapy 48
Report on Task 3.3 activities Clinical research on biomarkers 47
Biohumoral predictors of coronary atherosclerosis progression in patients with suspected coronary artery disease from the SMARTool Study 47
HDL cholesterol, leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain 47
Impact of Clinical Characteristics and Statins on Coronary Plaque Progression by Serial Computed Tomography Angiography 47
Expression profile of microRNAs in cardiac tissue from pediatric patients with heart failure (HF) supported by Ventricular Assist Device and their involvement in pathophysiological mechanisms of HF 47
High molecular weight adiponectin is increased in plasma of patients with idiopathic dilated cardiomyopathy with and without over heart failure. 47
COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? 46
Time-course of plasma NT-pro C-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant. 46
MR-PROADM PLASMA LEVELS ARE INCREASED IN OBESE ADOLESCENTS 46
Reappraisal of Quantitative Gel Zymography for Matrix Metalloproteinases 45
Aging and biomarkers: Transcriptional levels evaluation of Osteopontin/miRNA-181a axis in hepatic tissue of rats in different age ranges 45
Obesity modulates the transcriptional alterations of the natriuretic peptide and endothelin systems 44
[Adrenomedullin plasma levels as indicators of prognosis after cardiac resynchronization therapy]. 44
Osteoprotegerin as a marker of atherosclerosis and severity of CAD in patients candidate to cardiac imaging. 44
Elevated triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina. 44
Improving diagnostic yield of exercise ECG for obstructive coronary artery disease: integration with clinical and bio-humoral markers. 44
Uncovering the cathepsin system in heart failure patients submitted to Left Ventricular Assist Device (LVAD) implantation 44
Adenosine Receptor Transcriptomic Profile in Cardiac Tissue of a Zucker Rat Model. 43
Comparison of different immunoassays for total adiponectin in human plasma of patients with dilated cardiomyopathy cardiometabolic biomarkers in a swine model of myocardial infarction 43
PLASMA ADIPONECTIN LOWERING AFTER LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION IS ASSOCIATED WITH 1-MONTH SURVIVAL IN PATIENTS WITH ADVANCED HEART FAILURE 42
Espressione di heat shock proteins nel cuore e indici di danno d'organo. 42
A common plasma lipidomics signature of cardiometabolic and coronary risk in statin users 42
Spazio fisico e identità - Abitare Via Moruzzi 1 42
A modular informatics platform for effective support of collaborative and multicenter studies in cardiology 42
Back to the heart: The protective role of adiponectin 41
Adiponectin and Cardiovascular Risk Prediction: Stratification of Chest Pain Patients by a Cluster Analysis 41
LEFT VENTRICULAR ASSIST DEVICE ACTIVATES THE TRANSCRIPTIONAL APOPTOTIC PROFILE IN HUMAN HEART 41
Plasma Adiponectin Lowering after left Ventricular Assist Device Implantation is Associated with 1-Month Survival in Patients with Advanced Heart Failure 41
EFFECTIVENESS AND COSTS OF DIFFERENT STRATEGIES FOR THE DIAGNOSIS OF STABLE CORONARY ARTERY DISEASE RESULTS FROM THE EVINCI STUDY 41
La malattia del microcircolo coronarico nella disfunzione ventricolare sinistra: dai modelli sperimentali alla clinica. 40
ENDOTHELIN SYSTEM mRNA VARIATION IN THE HEART OF ZUCKER RATS: EVALUATION OF A POSSIBLE BALANCE WITH NATRIURETIC PEPTIDES 40
Anatomical and functional coronary imaging to predict long-term outcome in patients with suspected coronary artery disease: the EVINCI-outcome study. 40
Heat shock proteins (HSP72, HSP70, HSP60, HSP27) following cardioplegic arrest in human hearts 40
Apoptosis markers in the heart of minipigs with left ventricular pacing-induced heart failure 40
Inflammatory activation during maximal physical effort predicts specific membrane damage of cardiomyocytes 40
Detection of significant coronary artery disease by noninvasive anatomical and functional imaging. 40
Heme oxygenase-1 in patients with idiopathic left ventricular and coronary microvascular dysfunction: relationship with diabetes/insulin resistance 40
Adiponectin receptor, AdipoR1, is reduced in failing heart: study in an experimental model of pacing induced heart failure 39
Totale 5.666
Categoria #
all - tutte 27.382
article - articoli 21.977
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.014
Totale 50.373


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202449 0 0 0 0 0 0 0 0 1 5 36 7
2024/20253.239 50 17 285 107 612 170 71 163 150 241 766 607
2025/20265.268 234 339 550 807 1.132 284 817 179 310 350 266 0
Totale 8.556